rs10253216
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs10253216(A;A) |
Make rs10253216(A;G) |
Make rs10253216(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 7 |
Position | 16822225 |
is a | snp |
is | mentioned by |
dbSNP | rs10253216 |
dbSNP (classic) | rs10253216 |
ClinGen | rs10253216 |
ebi | rs10253216 |
HLI | rs10253216 |
Exac | rs10253216 |
Gnomad | rs10253216 |
Varsome | rs10253216 |
LitVar | rs10253216 |
Map | rs10253216 |
PheGenI | rs10253216 |
Biobank | rs10253216 |
1000 genomes | rs10253216 |
hgdp | rs10253216 |
ensembl | rs10253216 |
geneview | rs10253216 |
scholar | rs10253216 |
rs10253216 | |
pharmgkb | rs10253216 |
gwascentral | rs10253216 |
openSNP | rs10253216 |
23andMe | rs10253216 |
SNPshot | rs10253216 |
SNPdbe | rs10253216 |
MSV3d | rs10253216 |
GWAS Ctlg | rs10253216 |
GMAF | 0.3613 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23648065] |
Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin) |
Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
Risk Allele | T |
P-val | 2E-7 |
Odds Ratio | 1.48 [1.155-1.891] |